Pain Terminator Extra Strength Pain Relief Drug Recall
Ultra Seal Corporation is recalling PAIN TERMINATOR extra strength pain relief packets nationwide due to cGMP (current Good Manufacturing Practice) deviations detected during manufacturing. The recall affects 1,188,280 packets of the product.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II drug recall with no reported illnesses or injuries. The hazard is a manufacturing practice deviation without evidence of actual product harm or contamination. Class II recalls without health outcome reports typically fall into the Moderate category.
Plain-English summary
Ultra Seal Corporation is recalling PAIN TERMINATOR extra strength pain relief tablets (containing aspirin 162 mg, acetaminophen 110 mg, caffeine 32.4 mg, and salicylamide 152 mg) distributed in 2-tablet packets. The product was manufactured for Tellus Medical Products, Palm Desert, California, with NDC number 69103-2507.
The recall was initiated on January 24, 2022, due to cGMP deviations identified during manufacturing. The affected lot is AK9451 with an expiration date of January 2022. Approximately 1,188,280 packets were distributed nationwide within the United States.
Consumers who have purchased this product should stop using it. The recall was voluntary and initiated by the firm with notification by letter. The FDA classified this as a Class II recall. The recall status was terminated on October 16, 2023.
The recalled product
- Product
- PAIN TERMINATOR extra strength pain relief (aspirin 162 mg, acetaminophen 110 mg, Caffeine 32.4mg, Salicylamide 152 mg) 2 tablet packets, Manufactured for: Tellus Medical Products, Palm Desert, CA 92211, NDC 69103-2507
- Manufacturer
- Ultra Seal Corporation
- Hazard
- cgmp-deviation
- manufacturing-defect
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: AK9451
- Exp. Date 01/2022
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27